Brown Advisory Inc. Makes New Investment in Kestra Medical Technologies, Ltd. (NASDAQ:KMTS)

Brown Advisory Inc. acquired a new position in Kestra Medical Technologies, Ltd. (NASDAQ:KMTS - Free Report) during the first quarter, according to its most recent 13F filing with the SEC. The firm acquired 550,418 shares of the company's stock, valued at approximately $13,716,000. Brown Advisory Inc. owned 1.07% of Kestra Medical Technologies at the end of the most recent reporting period.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently issued reports on the company. Bank of America started coverage on Kestra Medical Technologies in a research note on Monday, March 31st. They issued a "buy" rating and a $30.00 target price for the company. Stifel Nicolaus assumed coverage on Kestra Medical Technologies in a report on Monday, March 31st. They set a "buy" rating and a $28.00 target price on the stock. The Goldman Sachs Group cut their price target on Kestra Medical Technologies from $24.00 to $23.00 and set a "neutral" rating on the stock in a report on Wednesday, April 16th. Wells Fargo & Company assumed coverage on Kestra Medical Technologies in a report on Monday, March 31st. They issued an "overweight" rating and a $28.00 price target on the stock. Finally, Piper Sandler assumed coverage on Kestra Medical Technologies in a research note on Monday, March 31st. They set an "overweight" rating and a $27.00 target price on the stock. One investment analyst has rated the stock with a hold rating and five have assigned a buy rating to the company's stock. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $27.50.

Kestra Medical Technologies Trading Down 1.8%

KMTS traded down $0.28 during trading on Friday, reaching $14.91. 310,381 shares of the stock traded hands, compared to its average volume of 458,089. Kestra Medical Technologies, Ltd. has a fifty-two week low of $14.02 and a fifty-two week high of $26.15. The firm's 50-day moving average price is $19.53.

Kestra Medical Technologies (NASDAQ:KMTS - Get Free Report) last posted its quarterly earnings data on Monday, April 14th. The company reported ($1.25) earnings per share for the quarter, missing the consensus estimate of ($0.64) by ($0.61). During the same period last year, the business earned ($1.18) earnings per share.

Kestra Medical Technologies Profile

We are a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. We have developed and are commercializing our Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution.